Cantor Fitzgerald Comments on Nano-X Imaging FY2025 Earnings

Nano-X Imaging Ltd. (NASDAQ:NNOX) – Analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for Nano-X Imaging in a report released on Tuesday, April 1st. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will post earnings of ($0.71) per share for the year, down from their previous estimate of ($0.61). Cantor Fitzgerald has a “Overweight” rating and a $9.00 price target on the stock. The consensus estimate for Nano-X Imaging’s current full-year earnings is ($0.92) per share.

Separately, D. Boral Capital reaffirmed a “buy” rating and set a $15.00 target price on shares of Nano-X Imaging in a research report on Monday.

Nano-X Imaging Trading Down 4.9 %

Shares of Nano-X Imaging stock opened at $4.67 on Thursday. The business’s fifty day simple moving average is $6.32 and its 200 day simple moving average is $6.61. Nano-X Imaging has a 12 month low of $4.58 and a 12 month high of $11.39. The firm has a market capitalization of $269.83 million, a P/E ratio of -5.49 and a beta of 1.99.

Nano-X Imaging (NASDAQ:NNOX) last posted its earnings results on Monday, March 31st. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.08). The firm had revenue of $3.00 million for the quarter, compared to the consensus estimate of $3.80 million. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NNOX. Northern Trust Corp increased its stake in shares of Nano-X Imaging by 71.3% during the 4th quarter. Northern Trust Corp now owns 621,365 shares of the company’s stock worth $4,474,000 after purchasing an additional 258,580 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in Nano-X Imaging during the fourth quarter valued at $459,000. Barclays PLC increased its position in Nano-X Imaging by 258.5% in the third quarter. Barclays PLC now owns 86,181 shares of the company’s stock worth $523,000 after buying an additional 62,140 shares during the last quarter. Headlands Technologies LLC bought a new stake in shares of Nano-X Imaging in the fourth quarter valued at $389,000. Finally, ARK Investment Management LLC lifted its position in shares of Nano-X Imaging by 19.0% during the 4th quarter. ARK Investment Management LLC now owns 300,757 shares of the company’s stock valued at $2,165,000 after buying an additional 48,124 shares during the last quarter. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.